GoodRx talks $520 million term loan at Libor plus 350 bps to 375 bps

New York, Sept. 25 – GoodRx set talk on its $520 million seven-year term loan (B1/B+) with the launch of its new credit facility at a bank meeting in New York on Tuesday, according to a market source.

The term loan is talked at Libor plus 350 basis points to 375 bps with a 0% Libor floor and an original issue discount of 99.5.

There is soft call protection at 101 for six months.

Commitments are due on Oct. 9.

The $560 million facility also includes a $40 million revolver, and there is a $225 million second-lien term loan that has been privately placed.

Goldman Sachs Bank USA, Barclays, Bank of America Merrill Lynch, Credit Suisse Securities (USA) LLC, KKR Capital Markets, Citizens and SunTrust Robinson Humphrey Inc. are the leads on the deal.

Proceeds will be used to help fund the acquisition of a significant minority stake in the company by Silver Lake Partners from existing owners Francisco Partners, Spectrum Equity and management.

Santa Monica, Calif.-based GoodRx operates a prescription drug price comparison and coupon platform.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.